BHCM
TECH icon

Brevan Howard Capital Management’s Bio-Techne TECH Stock Holding History

Brevan Howard Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,182
Closed -$952K – 2483
2025
Q4 		$952K Sell
16,182
-8,146
-33% -$495K 0.01% 795
2025
Q3 		$1.35M Buy
+24,328
New +$1.3M 0.01% 762

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brevan Howard Capital Management's TECH Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 16,182 shares — an estimated $952K sold.

Brevan Howard Capital Management first reported a position in TECH in Q3 2025 and held it in 2 quarters. The position peaked at $1.35M in Q3 2025. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 16,182 Bio-Techne shares in Q1 2026, an estimated $952K.
  • Brevan Howard Capital Management first reported a position in Bio-Techne in Q3 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Bio-Techne position peaked at $1.35M in Q3 2025.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.